Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

101.90
CHF
+49.04
(+92.78%)
3.36EPS
Feb 23Next Earn

Halozyme Therapeutics, Inc. Documents

Q2 FY2025 · Quarterly report

August 5, 2025 · 62 pages

Read Halozyme Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q2 FY2025 documents